☆ 4.7 Article

The Anti-COVID-19 Drug Remdesivir Promotes Oncogenic Herpesvirus Reactivation through Regulation of Intracellular Signaling Pathways

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Related references

Note: Only part of the references are listed.

Letter Ophthalmology

A Case of Acute Retinal Necrosis Associated with Reactivation of Varicella Zoster Virus after COVID-19 Vaccination

Seima Iwai et al.

Summary: A case of acute retinal necrosis (ARN) after COVID-19 vaccination is reported. A 78-year-old man developed blurred vision and floaters in the right eye 2 days after receiving the BNT162b2 mRNA-based COVID-19 vaccine. Subsequently, his visual acuity worsened and he was diagnosed with ARN. PCR testing of vitreous fluid sample confirmed the presence of varicella-zoster virus (VZV) DNA. Systemic antiviral and corticosteroid treatment alleviated the ocular inflammation, but the patient later experienced total retinal detachment after the second vaccination.

OCULAR IMMUNOLOGY AND INFLAMMATION (2023)

Add to Collection

Article Ophthalmology

Acute Retinal Necrosis from Reactivation of Varicella Zoster Virus following BNT162b2 mRNA COVID-19 Vaccination

Franklin Zheng et al.

Summary: This case report describes a case of acute retinal necrosis (ARN) due to varicella zoster virus (VZV) following COVID-19 vaccine administration. It suggests that COVID-19 mRNA vaccination may trigger an immunomodulatory response leading to reactivation of dormant VZV. Early recognition and treatment can improve visual outcomes.

OCULAR IMMUNOLOGY AND INFLAMMATION (2022)

Add to Collection

Article Biology

SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus

Jungang Chen et al.

Summary: The study reveals that SARS-CoV-2 encoded proteins and some anti-COVID-19 drugs can induce lytic reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV), increasing the risk of virus-associated cancers for KSHV-positive patients exposed to COVID-19 or undergoing its treatment, even after they have fully recovered from COVID-19.

COMMUNICATIONS BIOLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Clinical features and outcomes of adults with coronavirus disease 2019: A systematic review and pooled analysis of the literature

Sadie Bennett et al.

Summary: The systematic literature review of COVID-19 patients admitted to hospitals revealed that fever and cough were the most common symptoms. Comorbidities such as hypertension and cardiovascular disease were prevalent, and severe adverse outcomes included acute respiratory distress syndrome, acute cardiac injury, acute kidney injury, and mortality.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Add to Collection

Letter Infectious Diseases

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited

Philippe Gautret et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)

Add to Collection

Article Medicine, General & Internal

Reactivation of herpes zoster after vaccination with an inactivated vaccine: A case report from Nepal

Sangam Shah et al.

Summary: COVID-19 infection is associated with various cutaneous symptoms, with some patients presenting herpes zoster as an initial sign. While cases of herpes zoster after COVID-19 vaccination are rare, this report highlights a case of a 51-year-old male developing herpes zoster after receiving Sinopharm (Vero cell) vaccine.

CLINICAL CASE REPORTS (2021)

Add to Collection

Article Infectious Diseases

High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19

A. Simonnet et al.

Summary: Critically ill patients with COVID-19 in the ICU are prone to herpesvirus reactivation, particularly with EBV, which occurs early and is associated with longer ICU stays.

INFECTIOUS DISEASES NOW (2021)

Add to Collection

Letter Microbiology

Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19

Markus Hoffmann et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Add to Collection

Review Virology

Regulation of KSHV Latency and Lytic Reactivation

Grant Broussard et al.

VIRUSES-BASEL (2020)

Add to Collection

Letter Critical Care Medicine

Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients

Pierre Le Balc'h et al.

CRITICAL CARE (2020)

Add to Collection

Article Virology

Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5′-AMP-Activated Protein Kinase

Fan Cheng et al.

JOURNAL OF VIROLOGY (2016)

Add to Collection

Review Microbiology

The Role of Gammaherpesviruses in Cancer Pathogenesis

Hem Chandra Jha et al.

PATHOGENS (2016)

Add to Collection

Article Biochemistry & Molecular Biology

PKC theta and p38 MAPK activate the EBV lytic cycle through autophagy induction

Roberta Gonnella et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)

Add to Collection

Article Virology

STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus

Christine A. King et al.

JOURNAL OF VIROLOGY (2015)

Add to Collection

Article Oncology

Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression

Lu Dai et al.

ONCOTARGET (2015)

Add to Collection

Review Oncology

Regulation of the latent-lytic switch in Epstein-Barr virus

Shannon C. Kenney et al.

SEMINARS IN CANCER BIOLOGY (2014)

Add to Collection

Article Virology

Signal Transducer and Activator of Transcription 3 Limits Epstein-Barr Virus Lytic Activation in B Lymphocytes

Erik R. Hill et al.

JOURNAL OF VIROLOGY (2013)

Add to Collection

News Item Oncology

A review of human carcinogens-Part B: biological agents

Veronique Bouvard et al.

LANCET ONCOLOGY (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.